Renalytix plc - ADS (RNLXY)

CUSIP: 75973T101

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / ADS
Total 13F shares
4,404,591
Share change
-1,281,205
Total reported value
$5,637,000
Price per share
$1.28
Number of holders
25
Value change
-$3,180,156
Number of buys
15
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 75973T101?
CUSIP 75973T101 identifies RNLXY - Renalytix plc - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q3 2022

As of 30 Sep 2022, Renalytix plc - ADS (RNLXY) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,404,591 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Pentwater Capital Management LP, PINNACLE ASSOCIATES LTD, FRED ALGER MANAGEMENT, LLC, GW&K Investment Management, LLC, LAZARD ASSET MANAGEMENT LLC, GOFEN & GLOSSBERG LLC /IL/, Parian Global Management LP, Slate Path Capital LP, and MILLENNIUM MANAGEMENT LLC. This page lists 25 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.